Strikingly, pulsatile GnRH therapy improved cognition both in Ts65Dn mice and in DS patients, as shown in our pilot clinical trial,104 and pointed to optimal GnRH/LH pulsatility as being a necessary component for cognitive functions. The gene discussed is GNRH1; the disease is Dravet syndrome.